Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3062221000168119 | Citanest (prilocaine hydrochloride 50 mg / 5 mL) injection, 10 x 5 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3062231000168116 | Citanest 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Citanest 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Citanest 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | Is a | Citanest 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | true | Inferred relationship | Some | ||
| Citanest 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | has TPUU | Citanest 1% (50 mg/5 mL) injection, 5 mL ampoule | true | Inferred relationship | Some | 1 | |
| Citanest 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | has container type | ampoule | true | Inferred relationship | Some | ||
| Citanest 1% (50 mg/5 mL) injection, 10 x 5 mL ampoules | has TP | Citanest | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR